蓝丰生化
(002513)
| 流通市值：12.54亿 | | | 总市值：16.34亿 |
| 流通股本：2.94亿 | | | 总股本：3.84亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,789,655,236.86 | 1,260,661,605.24 | 652,131,097.94 | 2,342,107,165.64 |
| 营业收入 | 1,789,655,236.86 | 1,260,661,605.24 | 652,131,097.94 | 2,342,107,165.64 |
| 二、营业总成本 | 1,988,796,611.48 | 1,366,357,946.65 | 681,677,256.14 | 2,544,994,088.32 |
| 营业成本 | 1,760,152,272.94 | 1,217,005,428.97 | 612,193,620.34 | 2,268,760,983.95 |
| 税金及附加 | 12,325,972.8 | 8,204,513.23 | 4,206,809.05 | 17,800,167.32 |
| 销售费用 | 69,966,859.39 | 44,174,416.55 | 9,819,998.55 | 57,140,840.91 |
| 管理费用 | 63,713,940.52 | 41,124,337.08 | 35,276,536.09 | 90,557,639.09 |
| 研发费用 | 28,855,850.29 | 19,872,546.56 | 6,001,986.91 | 63,132,209.58 |
| 财务费用 | 53,781,715.54 | 35,976,704.26 | 14,178,305.2 | 47,602,247.47 |
| 其中:利息费用 | 39,472,045.68 | 28,806,553.07 | 13,364,557.56 | 53,542,140.24 |
| 其中:利息收入 | -5,729,877.44 | 4,062,399.89 | 2,576,584.11 | 6,846,819.64 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -3,333,543.98 | -3,333,543.98 | 6,623,621.82 | 2,381,382.19 |
| 资产处置收益 | 692,803.83 | 692,803.83 | 704,337.8 | -490,733.39 |
| 资产减值损失(新) | -39,764,677.6 | -31,976,118.97 | -10,650,431.19 | -80,941,989.04 |
| 信用减值损失(新) | 2,844,078.25 | 5,910,761.84 | -2,703,635.66 | -22,180,958.78 |
| 其他收益 | 12,175,228.1 | 8,245,154.87 | 3,878,636.26 | 20,007,035.87 |
| 四、营业利润 | -226,527,486.02 | -126,157,283.82 | -31,693,629.17 | -284,112,185.83 |
| 加:营业外收入 | 168,370.54 | 53,516.47 | 400,484.56 | 544,724.57 |
| 减:营业外支出 | 1,034,088.77 | 987,200.58 | 356,545.16 | 6,501,150.28 |
| 五、利润总额 | -227,393,204.25 | -127,090,967.93 | -31,649,689.77 | -290,068,611.54 |
| 减:所得税费用 | -33,571,443.2 | -16,171,789.97 | -4,011,015.33 | -18,286,770.15 |
| 六、净利润 | -193,821,761.05 | -110,919,177.96 | -27,638,674.44 | -271,781,841.39 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -193,821,761.05 | -110,919,177.96 | -27,638,674.44 | -271,781,841.39 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -104,873,779.75 | -59,803,668.07 | -14,841,689.9 | -190,525,337.53 |
| 少数股东损益 | -88,947,981.3 | -51,115,509.89 | -12,796,984.54 | -81,256,503.86 |
| 扣除非经常损益后的净利润 | -107,839,184.15 | -54,970,924.7 | -17,825,740.7 | -187,812,337.47 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.28 | -0.16 | -0.04 | -0.51 |
| (二)稀释每股收益 | -0.28 | -0.16 | -0.04 | -0.51 |
| 八、其他综合收益 | -1,029,484.41 | -1,029,484.41 | - | 891,217.38 |
| 归属于母公司股东的其他综合收益 | -1,029,484.41 | -1,029,484.41 | - | 944,888.44 |
| 九、综合收益总额 | -194,851,245.46 | -111,948,662.37 | -27,638,674.44 | -270,890,624.01 |
| 归属于母公司股东的综合收益总额 | -105,903,264.16 | -60,833,152.48 | -14,841,689.9 | -189,580,449.09 |
| 归属于少数股东的综合收益总额 | -88,947,981.3 | -51,115,509.89 | -12,796,984.54 | -81,310,174.92 |
| 公告日期 | 2026-10-28 | 2026-08-26 | 2026-04-30 | 2026-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |